These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12089592)

  • 1. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 2. Leadership management needs in evolving biotech companies.
    Föller A
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE64-6. PubMed ID: 12089593
    [No Abstract]   [Full Text] [Related]  

  • 3. Too little, too late: when is the right time for new leadership in biotech?
    Branthwaite P; Williams SJ
    Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591
    [No Abstract]   [Full Text] [Related]  

  • 4. Partnering challenges for startups.
    French JM
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE40-2. PubMed ID: 12089586
    [No Abstract]   [Full Text] [Related]  

  • 5. Syndication--value in numbers.
    Sanborn KT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE54-6. PubMed ID: 12089590
    [No Abstract]   [Full Text] [Related]  

  • 6. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing and the transitory nature of biotech startups.
    Bottles K
    Physician Exec; 2001; 27(4):55-7. PubMed ID: 11481895
    [No Abstract]   [Full Text] [Related]  

  • 8. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 9. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 10. Stranger in a strange land?
    Dahiyat B
    Nat Biotechnol; 2012 Nov; 30(11):1030-2. PubMed ID: 23138291
    [No Abstract]   [Full Text] [Related]  

  • 11. Converting biotech scientists into managers.
    Jensen DG; Dougherty E
    Nat Biotechnol; 2004 Mar; 22(3):357-8. PubMed ID: 15017990
    [No Abstract]   [Full Text] [Related]  

  • 12. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 13. Writing your business plan.
    Cohen L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE33-5. PubMed ID: 12089584
    [No Abstract]   [Full Text] [Related]  

  • 14. Value drivers in licensing deals.
    Arnold K; Coia A; Saywell S; Smith T; Minick S; Löffler A
    Nat Biotechnol; 2002 Nov; 20(11):1085-9. PubMed ID: 12410249
    [No Abstract]   [Full Text] [Related]  

  • 15. Getting reimbursement for your product in the United States.
    Gold M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE42-4. PubMed ID: 12874979
    [No Abstract]   [Full Text] [Related]  

  • 16. The habits of successful bioentrepreneurs.
    Hodgson J; Ward M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE3-5. PubMed ID: 12874969
    [No Abstract]   [Full Text] [Related]  

  • 17. Who took the tech out of biotech?
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 19. Good neighbours.
    Niiler E
    Nature; 2003 Dec; 426(6967):690-4. PubMed ID: 14668872
    [No Abstract]   [Full Text] [Related]  

  • 20. The challenge of leadership in technology and education.
    Chambers JW
    J Am Coll Dent; 2004; 71(4):22-5. PubMed ID: 15948489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.